Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Aathira Sujathan Nair, Ajay P. Jayan, K R Anandu, V N Saiprabha & Leena K. Pappachen. (2023) Unraveling the prevalence of various signalling pathways in non-small-cell lung cancer: a review. Molecular and Cellular Biochemistry 478:12, pages 2875-2890.
Crossref
Crossref
Min A. Park, Yeong Heon Lee & Mi-Jin Gu. (2023) High TEAD4 Expression is Associated With Aggressive Clear Cell Renal Cell Carcinoma, Regardless of YAP1 Expression. Applied Immunohistochemistry & Molecular Morphology.
Crossref
Crossref
Jiyoon Jung, Jeong Won Kim, Gilhyang Kim & Joo Young Kim. (2023) Low MST1/2 and negative LATS1/2 expressions are associated with poor prognosis of colorectal cancers. Pathology - Research and Practice 248, pages 154608.
Crossref
Crossref
Eriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, Maddalena Barba, Laura Pizzuti, Lorena Filomeno, Cristiana Ercolani, Nicola Tinari, Antonino Grassadonia, Daniele Santini, Mauro Minelli, Filippo Montemurro, Maria Agnese Fabbri, Marco Mazzotta, Teresa Gamucci, Giuliana D’Auria, Claudio Botti, Fabio Pelle, Flavia Cavicchi, Sonia Cappelli, Federico Cappuzzo, Giuseppe Sanguineti, Silverio Tomao, Andrea Botticelli, Paolo Marchetti, Marcello Maugeri-Saccà, Ruggero De Maria, Gennaro Ciliberto, Francesca Sperati & Patrizia Vici. (2022) The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study. Cancers 14:19, pages 4835.
Crossref
Crossref
Deepti Singh, Mohammad Afsar Khan & Hifzur R. Siddique. (2022) Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis. Biochemical Pharmacology 198, pages 114955.
Crossref
Crossref
Dimitrios Matthaios, Maria Tolia, Davide Mauri, Konstantinos Kamposioras & Michalis Karamouzis. (2021) YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Biomedicines 9:12, pages 1949.
Crossref
Crossref
Yanyan Han, Dandan Liu & Lianhong Li. (2021) Increased expression of TAZ and associated upregulation of PD-L1 in cervical cancer. Cancer Cell International 21:1.
Crossref
Crossref
Joo Young Kim, You‐Na Sung & Seung‐Mo Hong. (2021) High YAP and TEAD4 immunolabelings are associated with poor prognosis in patients with gallbladder cancer. APMIS 129:12, pages 729-742.
Crossref
Crossref
Frank Szulzewsky, Eric C. Holland & Valeri Vasioukhin. (2021) YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Developmental Biology 475, pages 205-221.
Crossref
Crossref
Yingxin Han, Liyan Ji, Yanfang Guan, Mengya Ma, Pansong Li, Yinge Xue, Yinxin Zhang, Wanqiu Huang, Yuhua Gong, Li Jiang, Xipeng Wang, Hong Xie, Boping Zhou, Jiayin Wang, Junwen Wang, Jinghua Han, Yuliang Deng, Xin Yi, Fei Gao & Jian Huang. (2021) An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single‐base resolution methylome and hydroxymethylome. Clinical and Translational Medicine 11:7.
Crossref
Crossref
Fanshun Wang, Hongqiang Zhang & Chunsheng Wang. (2020) MiR‐590‐3p regulates cardiomyocyte P19CL6 proliferation, apoptosis and differentiation in vitro by targeting PTPN1 via JNK/STAT/NF‐kB pathway. International Journal of Experimental Pathology 101:6, pages 196-202.
Crossref
Crossref
Leslie Olmedo-Nieva, J. Omar Muñoz-Bello, Joaquín Manzo-Merino & Marcela Lizano. (2020) New insights in Hippo signalling alteration in human papillomavirus-related cancers. Cellular Signalling 76, pages 109815.
Crossref
Crossref
Juan Zhao, Long Li & Ting Yang. (2020) MiR‐216a‐3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A‐mediated YAP signaling. Journal of Cellular Physiology 235:12, pages 9718-9728.
Crossref
Crossref
Joo Young Kim, Eun Kyung Kim, Won Mi Lee, Young Ok Hong & Hojung Lee. (2020) VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer. APMIS 128:10, pages 543-551.
Crossref
Crossref
Joseph A. Clara, Cecilia Monge, Yingzi Yang & Naoko Takebe. (2019) Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update. Nature Reviews Clinical Oncology 17:4, pages 204-232.
Crossref
Crossref
Tingting Yu, Ke Hu, Qiufan Xu, Xueqin Xu, Chunyue Du, Yinyi Zhao, Sen Yan, Wei Wang, Shijia Tang, Shen Yue, Xiya Zhang, Danlei Wang, Feimin Zhang, Steven Yan Cheng & Ning Gu. (2020) An Easy‐to‐Fabricate Hydrogel Platform with Tunable Stiffness and Cell Anchorage: Validation of Its Feasibility in Modulating Sonic Hedgehog Signaling Pathway Physically. Macromolecular Materials and Engineering 305:4, pages 1900759.
Crossref
Crossref
Jiashu Hu, Changle Ji, Kaiyao Hua, Xuehui Wang, Xiaochong Deng, Jiayi Li, Dinny Graham & Lin Fang. (2020) Hsa_circ_0091074 regulates TAZ expression via microRNA‑1297 in triple negative breast cancer cells. International Journal of Oncology.
Crossref
Crossref
Francesca Reggiani, Giulia Gobbi, Alessia Ciarrocchi, Davide Carlo Ambrosetti & Valentina Sancisi. (2020) Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1873:1, pages 188341.
Crossref
Crossref
Eojin Kim, Bokyung Ahn, Harim Oh, Yoo Jin Lee, Jeong Hyeon Lee, Youngseok Lee, Chul Hwan Kim, Yang-Seok Chae & Joo Young Kim. (2019) High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer. Pathology 51:3, pages 261-267.
Crossref
Crossref
Elisa Melucci, Beatrice Casini, Livia Ronchetti, Laura Pizzuti, Francesca Sperati, Matteo Pallocca, Francesca De Nicola, Frauke Goeman, Enzo Gallo, Carla Azzurra Amoreo, Domenico Sergi, Irene Terrenato, Patrizia Vici, Luigi Di Lauro, Maria Grazia Diodoro, Edoardo Pescarmona, Maddalena Barba, Marco Mazzotta, Marcella Mottolese, Maurizio Fanciulli, Gennaro Ciliberto, Ruggero De Maria, Simonetta Buglioni & Marcello Maugeri-Saccà. (2018) Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy. Journal of Translational Medicine 16:1.
Crossref
Crossref
Francesca De Nicola, Frauke Goeman, Matteo Pallocca, Francesca Sperati, Laura Pizzuti, Elisa Melucci, Beatrice Casini, Carla Azzurra Amoreo, Enzo Gallo, Maria Grazia Diodoro, Simonetta Buglioni, Marco Mazzotta, Patrizia Vici, Domenico Sergi, Luigi Di Lauro, Maddalena Barba, Edoardo Pescarmona, Gennaro Ciliberto, Ruggero De Maria, Maurizio Fanciulli & Marcello Maugeri-Saccà. (2018) Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer. Oncogenesis 7:7.
Crossref
Crossref
Marcello Maugeri-Saccà & Ruggero De Maria. (2018) The Hippo pathway in normal development and cancer. Pharmacology & Therapeutics 186, pages 60-72.
Crossref
Crossref
Zaid Taha, Helena Janse van Rensburg & Xiaolong Yang. (2018) The Hippo Pathway: Immunity and Cancer. Cancers 10:4, pages 94.
Crossref
Crossref
Zhen-Qiang Sun, Ke Shi, Quan-Bo Zhou, Xiang-Yue Zeng, Jinbo Liu, Shuai-Xi Yang, Qi-San Wang, Zhen Li, Gui-Xian Wang, Jun-Min Song, Wei-Tang Yuan & Hai-Jiang Wang. (2017) MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway. Oncotarget 8:35, pages 58061-58071.
Crossref
Crossref
Min Hwan Kim & Joon Kim. (2016) Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies. Cellular and Molecular Life Sciences 74:8, pages 1457-1474.
Crossref
Crossref